Eckelman Brendan P - Genomics Institute of the Novartis Research Foundation

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 17 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Drug-regulated CD33-targeted CAR T Cells Control AML Using Clinically Optimized Rapamycin Dosing

Jacob Appelbaum,April E. Price,Kaori Oda,Joy Zhang,Wai-Hang Leung,Giacomo Tampella,Dong Xia,Pauline P. L. So, Sarah K. Hilton,Claudya Evandy, Semanti Sarkar,Unja Martin,Anne-Rachel Krostag, Marissa Leonardi,Daniel E. Zak, Rachael Logan, Paula Lewis, Secil Franke-Welch, Njabulo Ngwenyama, Michael Fitzgerald, Niklas Tulberg,Stephanie Rawlings-Rhea,Rebecca A. Gardner,Kyle Jones,Angelica Sanabria,William Crago,John Timmer,Andrew Hollands,Brendan Eckelman,Sanela Bilic, Jim Woodworth,Adam Lamble, Philip D. Gregory,Jordan Jarjour,Mark Pogson,Joshua A. Gustafson,Alexander Astrakhan,Michael C. Jensen

JOURNAL OF CLINICAL INVESTIGATIONno. 9 (2024)

引用0浏览0WOS引用

Late Breaking Abstract - Validation of Assays Measuring Functional Alpha-1 Antitrypsin (AAT) in Patients with AAT Deficiency (AATD)

Jason Zour, Varun Ramani, Carolina Bellizzi, Buket Onel, Liz Nolff,Brendan Eckelman, Carson Veldstr

EUROPEAN RESPIRATORY JOURNAL (2023)

引用0浏览0引用

Development of a Multifunctional Third Generation Anti-Ige Therapeutic Candidate Antibody

Bryan Becklund, Andrew Eckles, Jacob Gano,Diane Dunham,Evan Do,Aykut Uren,Jared Lindenberger,Kari Nadeau,Tony Yao,Brendan Eckelman

The journal of allergy and clinical immunology/Journal of allergy and clinical immunology/The journal of allergy and clinical immunologyno. 2 (2022): AB194-AB194

引用0浏览0引用

1077 Development of a Molecular Targeted Cytokine That Specifically Expands Vgamma9Vdelta2 T Cells and Potentiates Anti-Tumor Activity

Bryan Becklund,Kaitlyn Robinson,Kyle Jones,Angelica Sanabria, Elisebeth Torretti, Andrew Eckles,Abrahim Hussain,Sae Jeong Ahn,Rajay Pandit,Florian Sulzmaier,John Timmer,Brendan Eckelman

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022): A1119-A1119

引用0浏览0引用

722 INBRX-121 is an NKp46-targeted Detuned IL-2 with Antitumor Activity As a Monotherapy or in Combination with Multiple Cancer Immunotherapy Modalities

Heather Kinkead,Chelsie Macedo,Angelica Sanabria,Rajay Pandit,Florian Sulzmaier,John Timmer,Brendan Eckelman,Analeah Heidt,Anya Polovina,Nadja Kern,Abrahim Hussain,Sae Jeong Ahn,William Crago

Journal for ImmunoTherapy of Cancer（2021）

引用2浏览0引用

856 INBRX-106: a Novel Hexavalent Anti-Ox40 Agonist for the Treatment of Solid Tumors

Quinn Deveraux,Heather Kinkead,Kyle Jones,Bryan Becklund,Florian Sulzmaier,John Timmer,Brendan Eckelman,Analeah Heidt,William Crago,Emily Rowell,Elisabeth Torretti

Journal for ImmunoTherapy of Cancer（2021）

引用5浏览0引用

Key pharmacokinetic and pharmacodynamic parameters that correlate with the anti-tumor activity of a bispecific pd-l1 conditional 4-1bb agonist

Heather Kinkead,Chelsie Macedo,Angelica Sanabria,Garrett Cyprus,Rajay Pandit, James Kalabus,Bryan Becklund,Florian Sulzmaier,John Timmer,Quinn Deveraux,Brendan Eckelman,Analeah Heidt

Journal for ImmunoTherapy of Cancerno. Suppl 2 (2021): A12-A12

引用2浏览0引用

Monoclonal Antibodies and Methods of Use

Sarah Rue,Eckelman Brendan,Deveraux Quinn,Nasoff Marc

mag（2015）

引用24浏览0引用

SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF

Brendan Eckelman,John Timmer,Peter L Nguy,Grant B Guenther,Quinn L Deveraux

mag（2015）

引用23浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn